drug fda - Search News

FDA announces end to Wegovy and Ozempic drug shortages

Reuters on MSN · 16h

Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list

Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's weight-loss and diabetes treatments Wegovy and Ozempic from its shortage list,

Compounders Sue FDA for Declaring Ozempic, Wegovy Shortage Over

The Outsourcing Facilities Association, a trade group representing compounders, filed a similar lawsuit in October last year after the FDA formally ended the tirzepaptide shortage.

USA TODAY on MSN · 3d

Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug is no longer on the FDA shortage list.

Medtronic gets FDA approval for Brainsense device

FDA approves first drug for rare lipid storage disease

An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day in the Readout newsletter.

US FDA approves Medtronic's medical device for Parkinson's disease

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.

Business Insider · 1d

Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no

21h

Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

22hon MSN

Pfizer Names Former FDA Drug Chief as Top Doctor

Pfizer Inc. appointed the Food and Drug Administration’s former top drug reviewer to serve as its chief medical officer.

Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...

19hon MSN

Pfizer hires ex-FDA drug chief as top doctor

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the ...

5hon MSN

Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

7h

Insight: Smokescreen: some vape firms pivot after FDA crackdown

Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...

19hon MSN

FDA moves to rehire medical device, food safety and other staffers fired days earlier

The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, ...

1d

Frozen shakes served at nursing homes recalled after being linked to numerous deaths, hospitalizations: FDA

The FDA announced that a food distributor is recalling all ReadyCare and Sysco Imperial Frozen Supplemental shakes, typically ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results